Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, released preliminary results for the first quarter of 2026. The release had been postponed due to internal investigations—now completed—regarding revenues and accounting practices in financial years 2024 and 2025.
South Korea-based Alteogen has signed an exclusive licensing deal worth up to $365m with a global pharmaceutical company, granting worldwide rights to develop and commercialise a subcutaneous biologic product using its Hybrozyme technology.
SCHOTT Pharma, a pioneer in drug containment solutions and delivery systems, has announced the development of cartriQ® BioPure, a new sterile glass cartridge. Featuring enhanced chemical resistance and an improved extractables and leachables profile, it is designed to meet the demanding requirements of modern biotech medicines.
SCHOTT Pharma and Nemera have strengthened their partnership to provide pharmaceutical companies with a reliable, fully verified platform for injectable therapies.
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
Halozyme Therapeutics has signed a global partnership and licence agreement with Incyte to assess additional subcutaneous formulations of INCA033989, a monoclonal antibody targeting mutant calreticulin (mutCALR), in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs).
Aptar Pharma has launched a collaborative system-level framework designed to support the development of injectable drug delivery systems.
SCHOTT Pharma, a pioneer in drug containment and delivery solutions, is investing more than €100m in its existing site in Lukácsháza, Hungary, to expand its capacity for sterile ready-to-use (RTU) cartridges.
SCHOTT Pharma, a pioneer in drug containment solutions and delivery systems, is proud to introduce a new small-volume, ready-to-use (RTU) cartridge for human use to the market.
SCHOTT Pharma, a pioneer in drug containment solutions and delivery systems, is introducing optimised SCHOTT TOPPAC® freeze polymer syringes, designed to protect medications at temperatures as low as -180°C.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.